John Mann has more than 20+ years’ experience in clinical research organizations and 25 years in management including non-industry experience. He has managed studies that covered very large clinical trial project teams in over 50 countries with responsibilities for coordinating all clinical trial services. Additionally, Mr. Mann has extensive global pediatric and rare/ultra-rare clinical trial experience. Mr. Mann has work at multiple CROs and currently works at ICON (formally PRA Healthsciences) for the last 10 years where he has lead the emerging biotech and rare disease operations business sections in project management. During his time at ICON he helped lead the risk based monitoring task force and in early 2021 he moved to the newly formed Decentralized Trials (DCT) Operations business unit to help lead and operationalize DCT studies within ICON. He obtained his Project Management Professional Certification from the Project Management Institute (PMI), six sigma green belt certification from NC State University, change management certification from PROSCI, and has obtained is MSc degree from North Carolina State University
